developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; SAR-bisPSMA, a theranostic ...

Metastatic prostate cancer is incurable, and novel methods to detect the disease earlier and to direct definitive treatment are needed. Molecularly specific tools to localize diagnostic and cytotoxic ...

Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutic agents that consist of small molecular drugs coupled to multifunctional peptides through cleavable or non-cleavable ...

The neuroendocrine system is most active at birth and may play a role in the transition from fetal to postnatal life, in particular in the lungs' transition from fluid secretion to fluid absorption.

Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Faculty of Pharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland ...

1 Department of Pediatrics, Turku University Central Hospital, Turku, Finland 2 Department of Allergy, Helsinki University Central Hospital, Skin and Allergy Hospital, Helsinki, Finland 3 Department ...

In May 2023, a novel tracer, flotufolastat F 18 (POSLUMA®), formerly referred to as 18 F-rhPSMA-7.3, was approved by the FDA as a PSMA-PET tracer for the staging of prostate cancer patients with a ...